| Date Filed | Type | Description |
| 10/04/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $25.6123, valued at
$128.1k
|
|
| 08/17/2023 |
4
| SASSINE ANDY (CFO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 1,223 shares
@ $17.374, valued at
$21.2k
|
|
| 08/03/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $34.91, valued at
$174.6k
|
|
| 08/03/2023 |
4
| Markels John (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| FARRELL PETER C (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| Marantz Jing L. (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| HOLMES EDWARD W (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| BARLOW JAMES F (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 08/03/2023 |
4
| Marquet Magda (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 11,869 options to buy
@ $34.92, valued at
$414.5k
Granted 3,131 restricted stock units
@ $0 |
|
| 07/18/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 25,000 shares
@ $35.01, valued at
$875.3k
|
|
| 07/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $28.75, valued at
$143.8k
|
|
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $25.38, valued at
$126.9k
|
|
| 03/08/2023 |
4
| Chivukula Pad (Chief Scientific Officer & COO) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Sold 5,000 shares
@ $16.07, valued at
$80.4k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| HOLMES EDWARD W (Director) has filed a Form 4 on Arcturus Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $16.02, valued at
$240.3k
|
|
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|